BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41:32-9. [PMID: 15690479 DOI: 10.1002/hep.20517] [Cited by in Crossref: 299] [Cited by in F6Publishing: 229] [Article Influence: 16.6] [Reference Citation Analysis]
Number Citing Articles
1 Kalaycı TM, Karadağ Erkoç S, Yılmaz AA. Evaluation of the Effects of Preoperative Sodium Values on Postoperative Period in Liver Transplant Patients. atfm 2022;75:328-334. [DOI: 10.4274/atfm.galenos.2022.38243] [Reference Citation Analysis]
2 Yang C, Xiong B. A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement. Portal Hypertension & Cirrhosis 2022;1:133-144. [DOI: 10.1002/poh2.28] [Reference Citation Analysis]
3 Jiang D, Ji T, Liu W, Bednarsch J, Selzner M, Pratschke J, Lurje G, Cao T, Brüggenwirth IMA, Martins PN, Arke Lang S, Peter Neumann U, Czigany Z. Four Decades of Clinical Liver Transplantation Research: Results of a Comprehensive Bibliometric Analysis. Transplantation 2022. [PMID: 35831925 DOI: 10.1097/TP.0000000000004224] [Reference Citation Analysis]
4 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
5 Micanovic R, LaFavers KA, Patidar KR, Ghabril MS, Doud EH, Mosley AL, Sabo AR, Khan S, El-Achkar TM. The kidney releases a non-polymerizing form of Uromodulin in the urine and circulation that retains the external hydrophobic patch domain. Am J Physiol Renal Physiol 2022. [PMID: 35100812 DOI: 10.1152/ajprenal.00322.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Latt NL, Niazi M, Pyrsopoulos NT. Liver transplant allocation policies and outcomes in United States: A comprehensive review. World J Methodol 2022; 12(1): 32-42 [DOI: 10.5662/wjm.v12.i1.32] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Praharaj DL, Anand AC. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis. J Clin Exp Hepatol 2022;12:575-94. [PMID: 35535075 DOI: 10.1016/j.jceh.2021.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Abbassi F, Toso C. Organ Donation, Distribution, and Allocation in the United States, Europe, and Asia. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_11] [Reference Citation Analysis]
9 Khan S, Cain O, Rajoriya N. Alcohol Related Liver Disease. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_11] [Reference Citation Analysis]
10 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ivanics T, Leonard-Murali S, Mouzaihem H, Moonka D, Kitajima T, Yeddula S, Shamaa MT, Rizzari M, Collins K, Yoshida A, Abouljoud M, Nagai S. Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD-sodium era. Transpl Int 2021. [PMID: 34580929 DOI: 10.1111/tri.14123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kaplan M, Ateş İ, Akdoğan M, Kaçar S, Gökbulut V, Coşkun O. The prognostic utility of ascites sodium level in cirrhotic patients. Akademik Gastroenteroloji Dergisi 2021. [DOI: 10.17941/agd.977865] [Reference Citation Analysis]
13 Zamberg I, Maillard J, Assouline B, Tomala S, Keli-Barcelos G, Aldenkortt F, Mavrakanas T, Andres A, Schiffer E. Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review. Hepat Med 2021;13:71-82. [PMID: 34393524 DOI: 10.2147/HMER.S320127] [Reference Citation Analysis]
14 Mazumder NR, Simpson D, Atiemo K, Jackson K, Zhao L, Daud A, Kho A, Gabra LG, Caicedo JC, Levitsky J, Ladner DP. Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study. Hepatology 2021;74:926-36. [PMID: 34128254 DOI: 10.1002/hep.31742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-48. [PMID: 33942342 DOI: 10.1002/hep.31884] [Cited by in Crossref: 92] [Cited by in F6Publishing: 69] [Article Influence: 46.0] [Reference Citation Analysis]
16 McDonald MF, Barrett SC, Malik TH, Anand A, Keeling SS, Christmann CR, Goff CR, Galvan T, Kanwal F, Cholankeril G, Goss J, Rana A. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int 2021. [PMID: 34218471 DOI: 10.1111/tri.13968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Jain V, Burford C, Alexander EC, Dhawan A, Joshi D, Davenport M, Heaton N, Hadzic N, Samyn M. Adult Liver Disease Prognostic Modelling for Long-term Outcomes in Biliary Atresia: An Observational Cohort Study. J Pediatr Gastroenterol Nutr 2021;73:93-8. [PMID: 33720092 DOI: 10.1097/MPG.0000000000003116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 21.0] [Reference Citation Analysis]
19 Sumarsono A, Wang J, Xie L, Chiang GC, Tielleman T, Messiah SE, Singal AG, Mufti A, Chen C, Leveno M. Prognostic Value of Hypochloremia in Critically Ill Patients With Decompensated Cirrhosis. Crit Care Med 2020;48:e1054-61. [PMID: 32947468 DOI: 10.1097/CCM.0000000000004620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Chung HS, Woo A, Chae MS, Hong SH, Park CS, Choi JH, Jo YS. Combined B-type Natriuretic Peptide as strong predictor of short-term mortality in patients after Liver Transplantation. Int J Med Sci 2021;18:2500-9. [PMID: 34104081 DOI: 10.7150/ijms.54202] [Reference Citation Analysis]
21 Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol 2021;33:541-6. [PMID: 32398491 DOI: 10.1097/MEG.0000000000001760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jensen MK, Kavan MA, Rodriguez-davalos M. Liver Transplantation in Children: Indications and Surgical Aspects. Liver Disease in Children 2021. [DOI: 10.1017/9781108918978.043] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Micanovic R, Lafavers KA, Patidar KR, Ghabril MS, Doud EH, Mosley AL, Sabo AR, Khan S, El-achkar TM. The kidney releases a non-polymerizing form of Uromodulin in the urine and circulation that retains the external hydrophobic patch domain.. [DOI: 10.1101/2021.02.26.21251982] [Reference Citation Analysis]
24 Castle-Kirszbaum M, Kyi M, Wright C, Goldschlager T, Danks RA, Parkin WG. Hyponatraemia and hypernatraemia: Disorders of Water Balance in Neurosurgery. Neurosurg Rev 2021. [PMID: 33389341 DOI: 10.1007/s10143-020-01450-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
25 Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, Braat AE. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region. Am J Transplant 2021;21:229-40. [PMID: 32529758 DOI: 10.1111/ajt.16142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
26 Hsu E, Schladt DP, Wey A, Perito ER, Israni AK. Improving the predictive ability of the pediatric end-stage liver disease score for young children awaiting liver transplant. Am J Transplant 2021;21:222-8. [PMID: 32306489 DOI: 10.1111/ajt.15925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 34.5] [Reference Citation Analysis]
28 Twomey C. The Patient Presenting for Liver Transplantation. Preoperative Assessment 2021. [DOI: 10.1007/978-3-030-58842-7_23] [Reference Citation Analysis]
29 Lenci I, Milana M, Grassi G, Signorello A, Aglitti A, Baiocchi L. Natremia and liver transplantation: The right amount of salt for a good recipe. World J Hepatol 2020; 12(11): 919-930 [PMID: 33312419 DOI: 10.4254/wjh.v12.i11.919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Bezinover D, Nahouraii L, Sviatchenko A, Wang M, Kimatian S, Saner FH, Stine JG. Hyponatremia Is Associated With Increased Mortality in Children on the Waiting List for Liver Transplantation. Transplant Direct 2020;6:e604. [PMID: 33134484 DOI: 10.1097/TXD.0000000000001050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
32 Malaquias MJ, Pinto CM, Ramos C, Ferreira S, Gandara J, Almeida A, Cavaco S, Miranda HP, Magalhães M. Acquired hepatocerebral degeneration and hepatic encephalopathy: one or two entities? Eur J Neurol 2020;27:2396-404. [DOI: 10.1111/ene.14486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Stącel T, Nęcki M, Latos M, Urlik M, Antończyk R, Kos A, Zawadzki F, Wajda-Pokrontka M, Przybyłowski P, Zembala M, Ochman M. Model for End-Stage Liver Disease (MELD) Score Among Patients Qualified For Lung Transplantation With End-Stage Lung Diseases With Particular Consideration of Median Pulmonary Artery Pressure. Transplant Proc 2020;52:2128-32. [PMID: 32553508 DOI: 10.1016/j.transproceed.2020.03.043] [Reference Citation Analysis]
34 Fallet E, Rayar M, Landrieux A, Camus C, Houssel-Debry P, Jezequel C, Legros L, Uguen T, Ropert-Bouchet M, Boudjema K, Guyader D, Bardou-Jacquet E. Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation. World J Gastroenterol 2020; 26(16): 1938-1949 [PMID: 32390704 DOI: 10.3748/wjg.v26.i16.1938] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol 2019;18:30-9. [PMID: 31113606 DOI: 10.5604/01.3001.0012.7859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Fábrega E, Huelin P, Fortea J, Crespo J. Ascitis. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:327-337. [DOI: 10.1016/j.med.2020.04.004] [Reference Citation Analysis]
37 Xu X, Lin S, Yang Y, Chen Y, Liu B, Li B, Wu Y, Meng F, Zhu Q, Li Y, Tang S, Yuan S, Shao L, Qi X. Development of hyponatremia after terlipressin in cirrhotic patients with acute gastrointestinal bleeding: a retrospective multicenter observational study. Expert Opin Drug Saf 2020;19:641-7. [PMID: 32101054 DOI: 10.1080/14740338.2020.1734558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant 2020;25:99-103. [PMID: 32073495 DOI: 10.1097/MOT.0000000000000732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang XH, Jiang XM, Gao PX, Liu Q, Yuan JH, Chen SJ. Risk factors and prognostic analysis of acute-on-chronic liver failure of chronic hepatitis B after cessation of nucleos(t)ide analogs. Eur J Gastroenterol Hepatol 2020;32:265-75. [PMID: 31789948 DOI: 10.1097/MEG.0000000000001574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Leventhal TM, Florek E, Chinnakotla S. Changes in liver allocation in United States. Current Opinion in Organ Transplantation 2020;25:52-8. [DOI: 10.1097/mot.0000000000000726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
41 Pereira G, Baldin C, Piedade J, Reis V, Valdeolivas T, Victor L, Guimarães L, Duarte J, Veiga Z, Alcântara C, Fernandes F, Pereira JL. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis 2020;52:91-7. [PMID: 31542220 DOI: 10.1016/j.dld.2019.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Choudhary NS, Sonavane A, Saraf N, Saigal S, Rastogi A, Bhangui P, Thiagrajan S, Yadav SK, Saha S, Soin AS. Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation. J Clin Exp Hepatol 2020;10:37-42. [PMID: 32025165 DOI: 10.1016/j.jceh.2019.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
43 Alsahhar JS, Elwir S. Epidemiology and Natural History of Chronic Liver Disease. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Wong F. Management of Ascites. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_2] [Reference Citation Analysis]
45 Freitas ACT, Rampim AT, Nunes CP, Coelho JCU. IMPACT OF MELD SODIUM ON LIVER TRANSPLANTATION WAITING LIST. Arq Bras Cir Dig 2019;32:e1460. [PMID: 31826087 DOI: 10.1590/0102-672020190001e1460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
46 Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol 2019;32:626-32. [PMID: 31700241 DOI: 10.20524/aog.2019.0417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
47 Adebayo D, Neong SF, Wong F. Ascites and Hepatorenal Syndrome. Clin Liver Dis 2019;23:659-82. [PMID: 31563217 DOI: 10.1016/j.cld.2019.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
48 Brock GN, Washburn K, Marvin MR. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing. PLoS One 2019;14:e0223053. [PMID: 31581270 DOI: 10.1371/journal.pone.0223053] [Reference Citation Analysis]
49 Chen PC, Chen BH, Huang CH, Jeng WJ, Hsieh YC, Teng W, Chen YC, Ho YP, Sheen IS, Lin CY. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2019;31:1256-63. [PMID: 31498284 DOI: 10.1097/MEG.0000000000001481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Maimone S, Mazzeo AT, Squadrito G, Raimondo G. Sodium load and intravenous antimicrobials in patients with cirrhosis. Dig Liver Dis 2019;51:1490-2. [PMID: 31439451 DOI: 10.1016/j.dld.2019.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kang SH, Jeong WK, Baik SK, Cha SH, Kim MY. Impact of sarcopenia on prognostic value of cirrhosis: Going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle. 2018;9:860-870. [PMID: 30371017 DOI: 10.1002/jcsm.12333] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
52 Burton AG, Hopper K. Hyponatremia in dogs and cats. Journal of Veterinary Emergency and Critical Care 2019;29:461-71. [DOI: 10.1111/vec.12881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Wang J, Zhang Z, Yan X, Li M, Xia J, Liu Y, Chen Y, Jia B, Zhu L, Zhu C, Huang R, Wu C. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Dig Liver Dis 2019;51:1172-8. [PMID: 30765220 DOI: 10.1016/j.dld.2019.01.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
54 Jain V, Burford C, Alexander EC, Sutton H, Dhawan A, Joshi D, Davenport M, Heaton N, Hadzic N, Samyn M. Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J Hepatol 2019;71:71-7. [PMID: 30876944 DOI: 10.1016/j.jhep.2019.03.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
55 Pillai A, Couri T, Charlton M. Liver Allocation Policies in the USA: Past, Present, and the Future. Dig Dis Sci 2019;64:985-92. [PMID: 30895482 DOI: 10.1007/s10620-019-05549-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
56 Asrani SK, Jennings LW, Trotter JF, Levitsky J, Nadim MK, Kim WR, Gonzalez SA, Fischbach B, Bahirwani R, Emmett M, Klintmalm G. A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction. Hepatology 2019;69:1219-30. [PMID: 30338870 DOI: 10.1002/hep.30321] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 8.8] [Reference Citation Analysis]
57 Allampati SK, Mullen KD. Understanding the impact of neurologic complications in patients with cirrhosis. SAGE Open Med. 2019;7:2050312119832090. [PMID: 30834114 DOI: 10.1177/2050312119832090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Jara M, Dziodzio T, Malinowski M, Lüttgert K, Nikolov R, Ritschl PV, Öllinger R, Pratschke J, Stockmann M. Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis. Dig Dis Sci 2019;64:576-84. [PMID: 30406480 DOI: 10.1007/s10620-018-5360-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Henke VG, Bokoch MP, Liu LL. Management of Hyponatremia in End-Stage Liver Disease. Critical Care for Potential Liver Transplant Candidates 2019. [DOI: 10.1007/978-3-319-92934-7_5] [Reference Citation Analysis]
60 Sumida Y, Kamada Y, Iwai M, Kwo PY, Yoneda M. Laboratory Tests in Liver Diseases. Diagnosis of Liver Disease 2019. [DOI: 10.1007/978-981-13-6806-6_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Petro CC, Haskins IN, Perez AJ, Tastaldi L, Strong AT, Ilie RN, Tu C, Krpata DM, Prabhu AS, Eghtesad B, Rosen MJ. Hernia repair in patients with chronic liver disease - A 15-year single-center experience. The American Journal of Surgery 2019;217:59-65. [DOI: 10.1016/j.amjsurg.2018.10.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
62 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
63 Neong SF, Adebayo D, Wong F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Rev Gastroenterol Hepatol 2019;13:293-305. [PMID: 30791777 DOI: 10.1080/17474124.2018.1555469] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
64 Wu SL, Zheng YX, Tian ZW, Chen MS, Tan HZ. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy. World J Clin Cases 2018; 6(15): 995-1006 [PMID: 30568954 DOI: 10.12998/wjcc.v6.i15.995] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
65 Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, Garcia-Martínez R, Moreira R, Torrens M, Márquez F, Fabrellas N, de Prada G, Huelin P, Lopez Benaiges E, Ventura M, Manríquez M, Nazar A, Ariza X, Suñé P, Graupera I, Pose E, Colmenero J, Pavesi M, Guevara M, Navasa M, Xiol X, Córdoba J, Vargas V, Ginès P. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. J Hepatol 2018;69:1250-9. [PMID: 30138685 DOI: 10.1016/j.jhep.2018.08.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 19.0] [Reference Citation Analysis]
66 Singh RR, Walia R, Sachdeva N, Bhalla A, Singh A, Singh V. Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome). Dig Liver Dis 2018;50:1232-7. [PMID: 29887344 DOI: 10.1016/j.dld.2018.05.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
67 Cheng Y, Wei GQ, Cai QC, Jiang Y, Wu AP. Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation. Chin Med J (Engl) 2018;131:1314-20. [PMID: 29786044 DOI: 10.4103/0366-6999.232798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Li C, Zhu B, Lv S, You S, Xin S. Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure. Medicine (Baltimore) 2018;97:e11915. [PMID: 30142800 DOI: 10.1097/MD.0000000000011915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
69 Bajaj JS, Tandon P, OʼLeary JG, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M, Thuluvath P, Vargas HE, Subramanian RM, Thacker LR, Reddy RK. The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis. Am J Gastroenterol 2018;113:1339. [PMID: 29880972 DOI: 10.1038/s41395-018-0119-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
70 Lopes-Secundo TM, Sevá-Pereira T, Correa BR, Silva NCM, Imbrizi MR, Cunha-Silva M, Soares EC, Almeida JRS. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection. Eur J Gastroenterol Hepatol 2018;30:1055-9. [PMID: 29944488 DOI: 10.1097/MEG.0000000000001184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
71 Jang CM, Jung YK. [Hyponatremia in Liver Cirrhosis]. Korean J Gastroenterol 2018;72:74-8. [PMID: 30145859 DOI: 10.4166/kjg.2018.72.2.74] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406-60. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 1113] [Cited by in F6Publishing: 1101] [Article Influence: 222.6] [Reference Citation Analysis]
73 Lindenmeyer CC, Kim A, Sanghi V, Lopez R, Niyazi F, Mehta NA, Flocco G, Kapoor A, Carey WD, Romero-Marrero C. The EMALT Score: An Improved Model for Prediction of Early Mortality in Liver Transplant Recipients. J Intensive Care Med 2020;35:781-8. [PMID: 29996705 DOI: 10.1177/0885066618784869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications. Clin Mol Hepatol 2018;24:230-77. [PMID: 29991196 DOI: 10.3350/cmh.2018.1005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
75 Kalra A, Biggins SW. New paradigms for organ allocation and distribution in liver transplantation. Curr Opin Gastroenterol 2018;34:123-31. [PMID: 29465430 DOI: 10.1097/MOG.0000000000000434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
76 Luo X, Leanza J, Massie AB, Garonzik-Wang JM, Haugen CE, Gentry SE, Ottmann SE, Segev DL. MELD as a metric for survival benefit of liver transplantation. Am J Transplant 2018;18:1231-7. [PMID: 29316310 DOI: 10.1111/ajt.14660] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
77 Rudkovskaia AA, Tonelli AR, Rao Y, Hammel JP, Buller GK, Dweik RA, Fares WH. Is hyponatremia associated with mortality in pulmonary arterial hypertension? Pulm Circ 2018;8:2045894018776888. [PMID: 29697294 DOI: 10.1177/2045894018776888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
78 Martino RB, Waisberg DR, Dias APM, Inoue VBS, Arantes RM, Haddad LBP, Rocha-Santos V, Pinheiro RSN, Nacif LS, D'Albuquerque LAC. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study. Transplant Proc 2018;50:754-7. [PMID: 29661430 DOI: 10.1016/j.transproceed.2018.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Lee YH, Huang YH, Lee FY, Hou MC, Huo TI. Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection. Sci Rep. 2018;8:4773. [PMID: 29555927 DOI: 10.1038/s41598-018-22923-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
80 Kim S, Zerillo J, Tabrizian P, Wax D, Lin HM, Evans A, Florman S, DeMaria S Jr. Postoperative Meld-Lactate and Isolated Lactate Values As Outcome Predictors Following Orthotopic Liver Transplantation. Shock 2017;48:36-42. [PMID: 28125529 DOI: 10.1097/SHK.0000000000000835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
81 Niewińsk G, Raszeja-Wyszomirska J, Główczyńska R, Figiel W, Zając K, Kornasiewicz O, Zieniewicz K, Grąt M. Risk Factors of Prolonged ICU Stay in Liver Transplant Recipients in a Single-Center Experience. Transplant Proc 2018;50:2014-7. [PMID: 30177100 DOI: 10.1016/j.transproceed.2018.02.143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
82 Cullaro G, Kim G, Pereira MR, Brown RS Jr, Verna EC. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Dig Dis Sci 2017;62:3487-94. [PMID: 29098551 DOI: 10.1007/s10620-017-4804-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
83 Nuthalapati A, Schluterman N, Khanna A, Greenberg D, Thuluvath PJ. Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis. J Clin Exp Hepatol 2017;7:290-9. [PMID: 29234192 DOI: 10.1016/j.jceh.2017.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
84 Huelin P, Fortea JI, Crespo J, Fábrega E. Ascites: Treatment, Complications, and Prognosis. Ascites - Physiopathology, Treatment, Complications and Prognosis 2017. [DOI: 10.5772/intechopen.70384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
86 Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One. 2017;12:e0186990. [PMID: 29065187 DOI: 10.1371/journal.pone.0186990] [Cited by in Crossref: 149] [Cited by in F6Publishing: 170] [Article Influence: 24.8] [Reference Citation Analysis]
87 Choden T, Satoskar R. MELD-Na: Does This Leave Anyone Behind? Curr Hepatology Rep 2017;16:220-227. [DOI: 10.1007/s11901-017-0356-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol 2017;67:517-25. [PMID: 28483678 DOI: 10.1016/j.jhep.2017.04.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
89 Jiménez JV, Carrillo-Pérez DL, Rosado-Canto R, García-Juárez I, Torre A, Kershenobich D, Carrillo-Maravilla E. Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach. Dig Dis Sci 2017;62:1855-71. [PMID: 28501971 DOI: 10.1007/s10620-017-4597-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
90 Moini M, Yazdani Sarvestani M, Shams M, Nomovi M. Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis. Can J Gastroenterol Hepatol. 2017;2017:2354253. [PMID: 28812008 DOI: 10.1155/2017/2354253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
91 Onnintsev IE, Ivanusa SY, Khokhlov AV, Sokolov AA, Yankovskiy AV. Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis. VESTNIK KHIRURGII IMENI I I GREKOVA 2017;176:32-37. [DOI: 10.24884/0042-4625-2017-176-3-32-37] [Reference Citation Analysis]
92 Enescu A, Petrescu F, Mitruţ P, Pădureanu V, Petrescu OI, Albu VC, Moraru AL, Enescu AŞ. Hyponatremia - unfavourable prognostic factor in hepatic cirrhosis. Rom J Intern Med 2016;54:207-10. [PMID: 28002032 DOI: 10.1515/rjim-2016-0036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Machicao VI. Model for End-Stage Liver Disease-Sodium Score: The Evolution in the Prioritization of Liver Transplantation. Clin Liver Dis 2017;21:275-87. [PMID: 28364813 DOI: 10.1016/j.cld.2016.12.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
94 Fortune B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep (Oxf). 2017;5:104-112. [PMID: 28533908 DOI: 10.1093/gastro/gox010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
95 Jackson KR, Cameron A. Liver Transplantation: Candidate Selection and Organ Allocation in the United States. Int Anesthesiol Clin 2017;55:5-17. [PMID: 28288029 DOI: 10.1097/AIA.0000000000000142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis. Liver Transpl 2017;23:155-65. [PMID: 28006875 DOI: 10.1002/lt.24702] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 9.5] [Reference Citation Analysis]
97 Sakai T, Zerillo J. Noteworthy Literature Published in 2016 for Abdominal Organ Transplantation Anesthesiologists. Semin Cardiothorac Vasc Anesth 2017;21:58-69. [PMID: 28100111 DOI: 10.1177/1089253216688536] [Reference Citation Analysis]
98 Devuni D, Ahmad J. Model for End-Stage Liver Disease (MELD) Score as a Biomarker. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_30] [Reference Citation Analysis]
99 Kaplan JB, Kalra A, Biggins SW. Liver Anatomy and Function. Radiation Therapy for Liver Tumors 2017. [DOI: 10.1007/978-3-319-54531-8_1] [Reference Citation Analysis]
100 Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores? Med Princ Pract. 2017;26:169-175. [PMID: 27676412 DOI: 10.1159/000451057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
101 Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant. 2016;21:120-126. [PMID: 26825358 DOI: 10.1097/mot.0000000000000281] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
102 Liamis G, Filippatos TD, Liontos A, Elisaf MS. Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise. Hepatol Int 2016;10:762-72. [DOI: 10.1007/s12072-016-9746-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
103 Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML, Ruíz-Cuesta P, Poyato-González A, Barrera-Baena P, Fraga-Rivas E, Costán-Rodero G, Briceño-Delgado J, Montero-Álvarez JL, de la Mata-García M. Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLoS One 2016;11:e0155822. [PMID: 27299728 DOI: 10.1371/journal.pone.0155822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
104 Corey KE, Kartoun U, Zheng H, Chung RT, Shaw SY. Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol 2016;111:671-6. [PMID: 26925881 DOI: 10.1038/ajg.2016.44] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
105 Lizaola B, Bonder A, Tapper EB, Mendez-bocanegra A, Cardenas A. The Changing Role of Sodium Management in Cirrhosis. Curr Treat Options Gastro 2016;14:274-84. [DOI: 10.1007/s11938-016-0094-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
106 Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol 2016; 22(10): 2922-2930 [PMID: 26973389 DOI: 10.3748/wjg.v22.i10.2922] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
107 Solà E, Huelin P, Ginès P. The Management of Hyponatremia in Cirrhosis: Should it Be Pharmacologic? Curr Hepatology Rep 2016;15:53-59. [DOI: 10.1007/s11901-016-0293-y] [Reference Citation Analysis]
108 Prohic D, Mesihovic R, Vanis N, Puhalovic A. Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores. Med Arch 2016;70:48-52. [PMID: 26980932 DOI: 10.5455/medarh.2016.70.48-52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
109 Devuni D, Ahmad J. Model for End-Stage Liver Disease (MELD) Score as a Biomarker. Biomarkers in Disease: Methods, Discoveries and Applications 2016. [DOI: 10.1007/978-94-007-7742-2_30-1] [Reference Citation Analysis]
110 Hong YF, Chen ZH, Ma XK, Li X, Wu DH, Chen J, Dong M, Wei L, Wang TT, Ruan DY, Lin ZX, Wen JY, Lin Q, Jia CC, Wu XY. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumour Biol 2016;37:5265-73. [PMID: 26561464 DOI: 10.1007/s13277-015-4366-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
111 Sinha VK, Ko B. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance. Adv Chronic Kidney Dis 2015;22:361-7. [PMID: 26311597 DOI: 10.1053/j.ackd.2015.02.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
112 Leventhal TM, Liu KD. What a Nephrologist Needs to Know About Acute Liver Failure. Adv Chronic Kidney Dis 2015;22:376-81. [PMID: 26311599 DOI: 10.1053/j.ackd.2015.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
113 Matloff RG, Arnon R. The Kidney in Pediatric Liver Disease. Curr Gastroenterol Rep 2015;17. [DOI: 10.1007/s11894-015-0457-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
114 Artru F, Louvet A. Admission des patients cirrhotiques en réanimation : le score de Child-Pugh est-il un outil pertinent ? Réanimation 2015;24:389-97. [DOI: 10.1007/s13546-015-1079-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Urso C, Brucculeri S, Caimi G. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions. J Clin Pharm Ther 2015;40:376-85. [PMID: 25924179 DOI: 10.1111/jcpt.12279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
116 Berardi R, Caramanti M, Castagnani M, Guglielmi S, Marcucci F, Savini A, Morgese F, Rinaldi S, Ferrini C, Tiberi M, Torniai M, Rovinelli F, Fiordoliva I, Onofri A, Cascinu S. Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support Care Cancer 2015;23:3095-101. [PMID: 25739755 DOI: 10.1007/s00520-015-2683-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
117 Asrani SK, Kamath PS. Evaluating prognosis. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch07] [Reference Citation Analysis]
118 Cárdenas A, Riggio O. Correction of hyponatraemia in cirrhosis: treating more than a number! J Hepatol 2015;62:13-4. [PMID: 25281862 DOI: 10.1016/j.jhep.2014.09.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
119 Fayad L, Narciso-Schiavon JL, Lazzarotto C, Ronsoni MF, Wildner LM, Bazzo ML, Schiavon Lde L, Dantas-Corrêa EB. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. Ann Hepatol 2015;14:83-92. [PMID: 25536645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
120 Ibrahim WA, Yoursy WA, Abdelhakam SM, Ahmed GA. Comparison between accuracy of different scoring systems in prediction of liver cirrhosis-related complications: . Egyptian Liver Journal 2015;5:6-14. [DOI: 10.1097/01.elx.0000459079.56315.44] [Reference Citation Analysis]
121 Cárdenas A, Solà E, Rodríguez E, Barreto R, Graupera I, Pavesi M, Saliba F, Welzel TM, Martinez-Gonzalez J, Gustot T. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care. 2014;18:700. [PMID: 25643318 DOI: 10.1186/s13054-014-0700-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
122 Facciorusso A, Amoruso A, Neve V, Antonino M, Prete VD, Barone M. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis. World J Hepatol 2014; 6(11): 793-799 [PMID: 25429317 DOI: 10.4254/wjh.v6.i11.793] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
123 Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, Biggins SW. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl 2014;20:1193-201. [PMID: 24916539 DOI: 10.1002/lt.23929] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
124 Umbro I, Tinti F, Fiacco F, Zavatto A, Piselli P, Di Natale V, Lai S, Vitarelli A, Corradini SG, Rossi M. Resistive index and MELD-Na: nephrologic monitoring in cirrhotic patients awaiting liver transplantation. Transplant Proc. 2013;45:2676-2679. [PMID: 24034022 DOI: 10.1016/j.transproceed.2013.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
125 Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014;60:1151-7. [PMID: 24607622 DOI: 10.1016/j.jhep.2014.02.026] [Cited by in Crossref: 245] [Cited by in F6Publishing: 236] [Article Influence: 27.2] [Reference Citation Analysis]
126 Ripoll C, Zipprich A, Garcia-tsao G. Prognostic Factors in Compensated and Decompensated Cirrhosis. Curr Hepatology Rep 2014;13:171-9. [DOI: 10.1007/s11901-014-0234-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
127 Farkas S, Hackl C, Schlitt HJ. Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med. 2014;4. [PMID: 24789874 DOI: 10.1101/cshperspect.a015602] [Cited by in Crossref: 42] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
128 Montasser MF, Abd El Moez AT, El-folly RF, Mohkles M. Addition of ‘serum sodium’ as a variable in the ‘model for end-stage liver disease’ scoring system. Egyptian Liver Journal 2014;4:29-35. [DOI: 10.1097/01.elx.0000445717.72960.ab] [Reference Citation Analysis]
129 Alexopoulou A, Vasilieva L, Kanellopoulou T, Pouriki S, Soultati A, Dourakis SP. Presence of spur cells as a highly predictive factor of mortality in patients with cirrhosis. J Gastroenterol Hepatol 2014;29:830-4. [PMID: 24325340 DOI: 10.1111/jgh.12473] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
130 Sakaida I. Tolvaptan for the treatment of liver cirrhosis oedema. Expert Rev Gastroenterol Hepatol 2014;8:461-70. [PMID: 24678622 DOI: 10.1586/17474124.2014.903797] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
131 Xun YH, Shi JP, Li CQ, Li D, Shi WZ, Pan QC, Guo JC, Zang GQ. Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure. Mol Med Rep 2014;9:1559-68. [PMID: 24573151 DOI: 10.3892/mmr.2014.1983] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
132 Gianotti RJ, Cardenas A. Hyponatraemia and cirrhosis. Gastroenterol Rep (Oxf) 2014;2:21-6. [PMID: 24760233 DOI: 10.1093/gastro/got037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
133 Prakoso E, Jones C, Koorey DJ, Strasser SI, Bowen D, McCaughan GW, Shackel NA. Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J 2013;43:240-6. [PMID: 23176166 DOI: 10.1111/imj.12032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
134 Teperman LW. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes. Int J Hepatol 2013;2013:952828. [PMID: 24324895 DOI: 10.1155/2013/952828] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
135 Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014;98:119-152. [PMID: 24266918 DOI: 10.1016/j.mcna.2013.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
136 Kasztelan-Szczerbinska B, Slomka M, Celinski K, Szczerbinski M. Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int. 2013;2013:614081. [PMID: 24151614 DOI: 10.1155/2013/614081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
137 Koo JK, Kim JH, Choi YJ, Lee CI, Yang JH, Yoon HY, Choi HJ, Ko SY, Choe WH, Kwon SY, Lee CH. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis. J Gastroenterol Hepatol 2013;28:1209-16. [PMID: 23425057 DOI: 10.1111/jgh.12156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
138 Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy. Liver Transpl 2013;19:711-20. [PMID: 23775946 DOI: 10.1002/lt.23665] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
139 Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19:105-115. [PMID: 23837134 DOI: 10.3350/cmh.2013.19.2.105] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 6.7] [Reference Citation Analysis]
140 Prié D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M, Eladari D, Lebrec D, Durand F, Friedlander G. Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. PLoS One 2013;8:e66182. [PMID: 23825530 DOI: 10.1371/journal.pone.0066182] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
141 Bertot LC, Gomez EV, Almeida LA, Soler EA, Perez LB. Model for End-Stage Liver Disease and liver cirrhosis-related complications. Hepatol Int 2013;7:347-55. [PMID: 26201769 DOI: 10.1007/s12072-012-9403-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Kim DH, Kim SH, Kim KS, Lee WJ, Kim NK, Noh SH, Kim CB. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices: Extrahepatic surgery in cirrhosis. ANZ J Surg 2014;84:832-6. [DOI: 10.1111/ans.12198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
143 Biyik M, Ucar R, Solak Y, Gungor G, Polat I, Gaipov A, Cakir OO, Ataseven H, Demir A, Turk S, Polat H. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2013;25:435-41. [PMID: 23249602 DOI: 10.1097/MEG.0b013e32835c2af3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 9.0] [Reference Citation Analysis]
144 Wallerstedt S, Simrén M, Wahlin S, Lööf L, Hultcrantz R, Sjöberg K, Gertzén HS, Prytz H, Almer S, Odén A. Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis. Scand J Gastroenterol 2013;48:358-65. [PMID: 23298384 DOI: 10.3109/00365521.2012.743583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
145 Lau T, Ahmad J. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013;5:1-10. [PMID: 24696621 DOI: 10.2147/hmer.s9049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
146 Solà E, Cárdenas A, Ginès P. Hyponatremia in Cirrhosis: Evaluation and Treatment. Hyponatremia 2013. [DOI: 10.1007/978-1-4614-6645-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Hope A, Morrison RS. What Special Considerations Are Needed for Treating Patients With Chronic Liver Disease? Evidence-Based Practice in Palliative Medicine 2013. [DOI: 10.1016/b978-1-4377-3796-7.00054-9] [Reference Citation Analysis]
148 Solà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, Pavesi M, Arroyo V, Guevara M, Ginès P. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012;57:1199-206. [PMID: 22824819 DOI: 10.1016/j.jhep.2012.07.020] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
149 Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF, Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant 2012;12:3191-212. [PMID: 23157207 DOI: 10.1111/j.1600-6143.2012.04259.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 8.1] [Reference Citation Analysis]
150 Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nat Rev Nephrol. 2013;9:37-50. [PMID: 23165296 DOI: 10.1038/nrneph.2012.246] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
151 Bachir NM, Larson AM. Adult liver transplantation in the United States. Am J Med Sci. 2012;343:462-469. [PMID: 22683615 DOI: 10.1097/maj.0b013e3182308b66] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
152 Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC; on behalf of the Liver Transplantation Group. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Clin Transplant 2012;26:E395-401. [DOI: 10.1111/j.1399-0012.2012.01688.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
153 Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61 [PMID: 22966483 DOI: 10.4292/wjgpt.v3.i4.49] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
154 Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol 2012;57:274-80. [PMID: 22521353 DOI: 10.1016/j.jhep.2012.03.018] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
155 Mukerji AN, Patel V, Jain A. Improving survival in decompensated cirrhosis. Int J Hepatol. 2012;2012:318627. [PMID: 22811919 DOI: 10.1155/2012/318627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
156 Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol 2012;28:230-8. [PMID: 22450898 DOI: 10.1097/MOG.0b013e3283527f16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
157 Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. The American Journal of Surgery 2012;203:589-93. [DOI: 10.1016/j.amjsurg.2012.01.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
158 Beck‐schimmer B. Anesthesia. Medical Care of the Liver Transplant Patient 2012. [DOI: 10.1002/9781444398441.ch24] [Reference Citation Analysis]
159 Kapoor ND, Goenka MK. Selection of patient for liver transplant. Apollo Medicine 2012;9:3-8. [DOI: 10.1016/s0976-0016(12)60113-6] [Reference Citation Analysis]
160 Levesque E, Hoti E, Azoulay D, Ichaï P, Habouchi H, Castaing D, Samuel D, Saliba F. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012;56:95-102. [PMID: 21835136 DOI: 10.1016/j.jhep.2011.06.024] [Cited by in Crossref: 129] [Cited by in F6Publishing: 125] [Article Influence: 11.7] [Reference Citation Analysis]
161 Sanyal AJ, Boyer TD. Renal Failure in Cirrhosis, Hepatorenal Syndrome, and Hyponatremia. Zakim and Boyer's Hepatology 2012. [DOI: 10.1016/b978-1-4377-0881-3.00021-8] [Reference Citation Analysis]
162 Felipe de Brito Galvao J, Center SA. Fluid, Electrolyte, and Acid-Base Disturbances in Liver Disease. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice 2012. [DOI: 10.1016/b978-1-4377-0654-3.00026-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
163 Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis 2011;15:685-98. [PMID: 22032523 DOI: 10.1016/j.cld.2011.08.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
164 Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92:469-476. [PMID: 21775931 DOI: 10.1097/tp.0b013e318225db4d] [Cited by in Crossref: 109] [Cited by in F6Publishing: 114] [Article Influence: 9.1] [Reference Citation Analysis]
165 Deitelzweig SB, McCormick L. Hyponatremia in hospitalized patients: the potential role of tolvaptan. Hosp Pract (1995) 2011;39:87-98. [PMID: 21881396 DOI: 10.3810/hp.2011.08.584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
166 Sharma P, Sharma BC. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose. Saudi J Gastroenterol. 2011;17:138-141. [PMID: 21372353 DOI: 10.4103/1319-3767.77246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
167 Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2011;54:1297-306. [PMID: 21145851 DOI: 10.1016/j.jhep.2010.11.008] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 9.0] [Reference Citation Analysis]
168 Obara-Michlewska M, Pannicke T, Karl A, Bringmann A, Reichenbach A, Szeliga M, Hilgier W, Wrzosek A, Szewczyk A, Albrecht J. Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: Implications for astrocytic dysfunction in hepatic encephalopathy. J Neurosci Res 2011;89:2018-27. [PMID: 21538466 DOI: 10.1002/jnr.22656] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
169 Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci 2011;56:977-87. [PMID: 20844956 DOI: 10.1007/s10620-010-1390-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
170 Guevara M, Ginès P. [Hyponatremia in liver cirrhosis: pathogenesis and treatment]. Endocrinol Nutr 2010;57 Suppl 2:15-21. [PMID: 21130958 DOI: 10.1016/S1575-0922(10)70018-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
171 Fenoglio I, Guy C, Beyens M, Mounier G, Marsille F, Mismetti P. Hyponatrémies d’origine médicamenteuse. À propos d’une série de 54 cas notifiés au Centre Régional de Pharmacovigilance de Saint-Étienne. Therapies 2011;66:139-48. [DOI: 10.2515/therapie/2011011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
172 Leithead JA, MacKenzie SM, Ferguson JW, Hayes PC. Is estimated glomerular filtration rate superior to serum creatinine in predicting mortality on the waiting list for liver transplantation? Transpl Int 2011;24:482-8. [PMID: 21362061 DOI: 10.1111/j.1432-2277.2011.01231.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
173 Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl 2011;17:129-36. [PMID: 21280185 DOI: 10.1002/lt.22218] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
174 Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011;124:77-84. [PMID: 21187188 DOI: 10.1016/j.amjmed.2010.07.029] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 9.3] [Reference Citation Analysis]
175 Choe WH. The use of vaptan in hyponatremic patients with liver cirrhosis. Korean J Hepatol 2011;17:335. [DOI: 10.3350/kjhep.2011.17.4.335] [Reference Citation Analysis]
176 Cárdenas A, Ginès P. Management of Ascites and Hyponatremia. Chronic Liver Failure 2011. [DOI: 10.1007/978-1-60761-866-9_21] [Reference Citation Analysis]
177 Cho HC, Jung HY, Sinn DH, Choi MS, Koh KC, Paik SW, Yoo BC, Kim SW, Lee JH. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score. Eur J Gastroenterol Hepatol 2011;23:51-9. [PMID: 21084989 DOI: 10.1097/MEG.0b013e3283407158] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
178 Eagar M. The patient with cirrhosis who presents for non-hepatic surgery. Southern African Journal of Anaesthesia and Analgesia 2011;17:120-123. [DOI: 10.1080/22201173.2011.10872754] [Reference Citation Analysis]
179 Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol 2010;7:659-68. [PMID: 21045793 DOI: 10.1038/nrgastro.2010.169] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
180 Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 2010;53:1135-45. [PMID: 20850887 DOI: 10.1016/j.jhep.2010.08.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
181 Moini M, Hoseini-asl MK, Taghavi SA, Sagheb MM, Nikeghbalian S, Salahi H, Bahador A, Motazedian M, Jafari P, Malek-hosseini SA. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation: Hyponatremia and liver list mortality. Clinical Transplantation 2011;25:638-45. [DOI: 10.1111/j.1399-0012.2010.01350.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
182 Solà E, Lens S, Guevara M, Martín-Llahí M, Fagundes C, Pereira G, Pavesi M, Fernández J, González-Abraldes J, Escorsell A, Mas A, Bosch J, Arroyo V, Ginès P. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology 2010;52:1783-90. [PMID: 20931555 DOI: 10.1002/hep.23893] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
183 Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, Moreau R, Lebrec D. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010;52:1017-22. [PMID: 20583214 DOI: 10.1002/hep.23775] [Cited by in Crossref: 366] [Cited by in F6Publishing: 279] [Article Influence: 28.2] [Reference Citation Analysis]
184 European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397-417. [PMID: 20633946 DOI: 10.1016/j.jhep.2010.05.004] [Cited by in Crossref: 1110] [Cited by in F6Publishing: 1165] [Article Influence: 85.4] [Reference Citation Analysis]
185 Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? Liver Transpl 2010;16:964-73. [PMID: 20677287 DOI: 10.1002/lt.22093] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
186 Ross E, Sigal SH. Managing hyponatremia in cirrhosis. J Hosp Med 2010;5 Suppl 3:S8-17. [PMID: 21157909 DOI: 10.1002/jhm.784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
187 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. Eur J Gastroenterol Hepatol 2010;22:526-31. [PMID: 20009938 DOI: 10.1097/MEG.0b013e3283341b7d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
188 Gonzalez SA, Trotter JF. Renal function and MELD: being direct is better. J Hepatol 2010;52:622-3. [PMID: 20347171 DOI: 10.1016/j.jhep.2010.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
189 Walker NM, Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology 2010;51:1683-91. [PMID: 20225256 DOI: 10.1002/hep.23537] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
190 Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol 2010;52:523-8. [PMID: 20185195 DOI: 10.1016/j.jhep.2010.01.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
191 Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH. Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl 2010;16:440-6. [PMID: 20205164 DOI: 10.1002/lt.22008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 35] [Article Influence: 0.6] [Reference Citation Analysis]
192 Lindsay A. Profound hyponatremia in cirrhosis: a case report. Cases J 2010;3:77. [PMID: 20331881 DOI: 10.1186/1757-1626-3-77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
193 Mannai S, Frikha N, Maghrebi H, Arfa N, Mestiri H, Khalfallah MT, Ammar MSB. The model of end-stage liver disease (MELD) score in predicting postoperative liver failure after hepatic resection of hepatocellular carcinoma in cirrhotic patients: The Tunisian experience. Arab Journal of Gastroenterology 2010;11:35-38. [DOI: 10.1016/j.ajg.2009.12.015] [Reference Citation Analysis]
194 Jenq CC, Tsai MH, Tian YC, Chang MY, Lin CY, Lien JM, Chen YC, Fang JT, Chen PC, Yang CW. Serum sodium predicts prognosis in critically ill cirrhotic patients. J Clin Gastroenterol 2010;44:220-6. [PMID: 19636261 DOI: 10.1097/MCG.0b013e3181aabbcd] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
195 Greenberg A, Lehrich RW. Treatment of Chronic Hyponatremia: Now We Know How, but Do We Know When or If? JASN 2010;21:552-5. [DOI: 10.1681/asn.2010020157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
196 Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N. Hyponatremia increases mortality in pediatric patients listed for liver transplantation. Pediatric Transplantation 2010;14:115-20. [DOI: 10.1111/j.1399-3046.2009.01142.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
197 Boyer TD. Tolvaptan and hyponatremia in a patient with cirrhosis. Hepatology 2010;51:699-702. [PMID: 20101750 DOI: 10.1002/hep.23522] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
198 Dancygier H. Liver Cirrhosis. Clinical Hepatology 2010. [DOI: 10.1007/978-3-642-04519-6_25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
199 Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD. Survival benefit after liver transplantation: a single European center experience. Transplantation. 2009;88:826-834. [PMID: 19920783 DOI: 10.1097/tp.0b013e3181b26807] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
200 Crawford DH, Stuart K. Adding serum sodium to model for end-stage liver disease: identifying those most at risk. J Gastroenterol Hepatol 2009;24:1804-6. [PMID: 20002937 DOI: 10.1111/j.1440-1746.2009.06028.x] [Reference Citation Analysis]
201 Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int 2009;29:1521-7. [PMID: 19725889 DOI: 10.1111/j.1478-3231.2009.02105.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
202 Kim MY, Baik SK, Yea CJ, Lee IY, Kim HJ, Park KW, Kim HK, Suk KT, Kim JW, Kim HS, Kwon SO, Cha SH, Kim YJ, Koh SB, Chang SJ. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol 2009;21:1241-6. [PMID: 19455045 DOI: 10.1097/MEG.0b013e32832a21c1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
203 Huang HC, Lee FY, Huo TI. Major adverse events, pretransplant assessment and outcome prediction. J Gastroenterol Hepatol 2009;24:1716-24. [PMID: 20136958 DOI: 10.1111/j.1440-1746.2009.06025.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
204 Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Dig Liver Dis 2009;41:700-6. [PMID: 19502118 DOI: 10.1016/j.dld.2009.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
205 Somsouk M, Guy J, Biggins SW, Vittinghoff E, Kohn MA, Inadomi JM. Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment Pharmacol Ther 2009;30:741-8. [PMID: 19604177 DOI: 10.1111/j.1365-2036.2009.04096.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
206 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int 2009;29:1365-71. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
207 Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72. [PMID: 19778459 DOI: 10.1186/1471-230X-9-72] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
208 Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857-865. [PMID: 19699382 DOI: 10.1016/j.amjmed.2009.01.027] [Cited by in Crossref: 441] [Cited by in F6Publishing: 368] [Article Influence: 31.5] [Reference Citation Analysis]
209 Hackworth WA, Heuman DM, Sanyal AJ, Fisher RA, Sterling RK, Luketic VA, Shiffman ML, Maluf DG, Cotterell AH, Posner MP, Stravitz RT. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int 2009;29:1071-7. [PMID: 19302181 DOI: 10.1111/j.1478-3231.2009.01982.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
210 Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am. 2009;93:931-950, ix. [PMID: 19577123 DOI: 10.1016/j.mcna.2009.03.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
211 Xu X, Ling Q, Zhang M, Gao F, He Z, You J, Zheng S. Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation. 2009;87:1514-1519. [PMID: 19461488 DOI: 10.1097/tp.0b013e3181a4430b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
212 Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 2009;7:793-9. [PMID: 19306949 DOI: 10.1016/j.cgh.2009.03.013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 6.6] [Reference Citation Analysis]
213 Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009;43:580-5. [PMID: 19197195 DOI: 10.1097/MCG.0b013e3181889468] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
214 Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation. 2009;87:763-770. [PMID: 19295324 DOI: 10.1097/tp.0b013e318198d734] [Cited by in Crossref: 111] [Cited by in F6Publishing: 113] [Article Influence: 7.9] [Reference Citation Analysis]
215 Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol 2009;44:346-57. [PMID: 18991165 DOI: 10.1080/00365520802530838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
216 Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009;49:1610-5. [PMID: 19402063 DOI: 10.1002/hep.22846] [Cited by in Crossref: 103] [Cited by in F6Publishing: 86] [Article Influence: 7.4] [Reference Citation Analysis]
217 Schrier RW, Bansal S. Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care. 2008;14:627-634. [PMID: 19005303 DOI: 10.1097/mcc.0b013e32830e45e3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
218 Xiol X, Gines P, Castells L, Twose J, Ribalta A, Fuentes-Arderiu X, Rodriguez S, Castellote J, Navasa M, Deulofeu R. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl 2009;15:300-5. [PMID: 19242993 DOI: 10.1002/lt.21688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
219 Scholze A, Tepel M. Hyponatriämie. Med Klin 2009;104:137-147. [DOI: 10.1007/s00063-009-1025-7] [Reference Citation Analysis]
220 Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009;9:318-26. [PMID: 19120079 DOI: 10.1111/j.1600-6143.2008.02491.x] [Cited by in Crossref: 221] [Cited by in F6Publishing: 213] [Article Influence: 15.8] [Reference Citation Analysis]
221 Campos-Varela I, Castells L. [Prognostic scores of cirrhosis]. Gastroenterol Hepatol 2008;31:439-46. [PMID: 18783690 DOI: 10.1157/13125591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
222 Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol 2009; 15(1): 67-80 [PMID: 19115470 DOI: 10.3748/wjg.15.67] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
223 Bagshaw SM, Bellomo R. Disorders of Sodium and Water Balance. Critical Care Nephrology 2009. [DOI: 10.1016/b978-1-4160-4252-5.50102-7] [Reference Citation Analysis]
224 Bagshaw SM, Townsend DR, McDermid RC. Disorders of sodium and water balance in hospitalized patients. Can J Anaesth 2009;56:151-67. [PMID: 19247764 DOI: 10.1007/s12630-008-9017-2] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
225 Jiang M, Liu F, Xiong WJ, Zhong L, Chen XM. Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis. World J Gastroenterol 2008; 14(42): 6546-6550 [PMID: 19030210 DOI: 10.3748/wjg.14.6546] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
226 Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Dig Liver Dis 2008;40:882-9. [PMID: 18339595 DOI: 10.1016/j.dld.2008.01.015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
227 Xia VW, Taniguchi M, Steadman RH. The changing face of patients presenting for liver transplantation. Curr Opin Organ Transplant. 2008;13:280-284. [PMID: 18685318 DOI: 10.1097/mot.0b013e328300a070] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
228 Bambha KM, Biggins SW. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions. Curr Opin Organ Transplant. 2008;13:227-233. [PMID: 18685308 DOI: 10.1097/MOT.0b013e3282ff84c7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
229 Lu BR, Gralla J, Liu E, Dobyns EL, Narkewicz MR, Sokol RJ. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol 2008;6:1140-5. [PMID: 18928939 DOI: 10.1016/j.cgh.2008.05.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
230 Cai C, Chen H, Lu M, Chen G. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B: . Chinese Medical Journal 2008;121:2065-9. [DOI: 10.1097/00029330-200810020-00023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
231 Heuman DM. Allocation in adult liver transplantation: is the Model for Endstage Liver Disease the solution? Liver Cirrhosis: From Pathophysiology to Disease Management. [DOI: 10.1007/978-1-4020-8656-4_29] [Reference Citation Analysis]
232 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa080120910.1053/jhep.2001.22172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa0801209] [Cited by in Crossref: 877] [Cited by in F6Publishing: 926] [Article Influence: 58.5] [Reference Citation Analysis]
234 Lo Iacono O, Rincón D, Hernando A, Ripoll C, Catalina MV, Salcedo M, Clemente G, Gomez J, Nuñez O, Matilla A, Bañares R. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis. Liver Int 2008;28:1129-35. [PMID: 18482273 DOI: 10.1111/j.1478-3231.2008.01763.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
235 Gane E. Predicting outcome in patients with cirrhosis following acute decompensation: can we do better? J Gastroenterol Hepatol 2008;23:1163-5. [PMID: 18699975 DOI: 10.1111/j.1440-1746.2008.05540.x] [Reference Citation Analysis]
236 Durand F. Ascite réfractaire : place de la transplantation hépatique. Gastroentérologie Clinique et Biologique 2008;32:721-726. [DOI: 10.1016/j.gcb.2008.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
237 Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl 2008;14:837-44. [PMID: 18508377 DOI: 10.1002/lt.21439] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
238 Walia A, Schumann R. The evolution of liver transplantation practices: . Current Opinion in Organ Transplantation 2008;13:275-9. [DOI: 10.1097/mot.0b013e3282ffabee] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
239 Cárdenas A, Ginès P. [Dilutional hyponatremia, hepatorenal syndrome and liver transplantation]. Gastroenterol Hepatol. 2008;31:29-36. [PMID: 18218278 DOI: 10.1157/13114568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
240 Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008;28:606-13. [PMID: 18433390 DOI: 10.1111/j.1478-3231.2008.01727.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
241 Zhang M, Li B, Yan LN, Yin F, Wen TF, Zeng Y, Zhao JC, Ma YK. Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol 2008; 14(8): 1280-1285 [PMID: 18300358 DOI: 10.3748/wjg.14.1280] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
242 Müllhaupt B, Dimitroulis D, Gerlach JT, Clavien PA. Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation. J Hepatol 2008;48 Suppl 1:S58-67. [PMID: 18308415 DOI: 10.1016/j.jhep.2008.01.013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
243 Mathur S, Gane EJ, McCall JL, Plank LD. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis. J Gastroenterol Hepatol 2008;23:239-43. [PMID: 17489965 DOI: 10.1111/j.1440-1746.2007.04891.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
244 Cárdenas A, Ginès P. What’s new in the treatment of ascites and spontaneous bacterial peritonitis. Curr Gastroenterol Rep 2008;10:7-14. [DOI: 10.1007/s11894-008-0003-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
245 Barrera P, Pleguezuelo M, Poyato A, de la Mata M. Modelos para definir receptores de alto riesgo y el momento del trasplante. Trasplante hepático 2008. [DOI: 10.1016/b978-84-8086-310-0.50003-8] [Reference Citation Analysis]
246 Kozak OS, Rabinstein AA. Hyponatremia in critical illness. Journal of Organ Dysfunction 2008;4:9-14. [DOI: 10.1080/17471060701272393] [Reference Citation Analysis]
247 Obstein KL, Campbell MS, Reddy KR, Yang YX. Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol 2007;102:2732-6. [PMID: 17714556 DOI: 10.1111/j.1572-0241.2007.01485.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
248 Selcuk H, Uruc I, Temel MA, Ocal S, Huddam B, Korkmaz M, Unal H, Kanbay M, Savas N, Gur G, Yilmaz U, Haberal M. Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Dig Dis Sci 2007;52:3217-23. [PMID: 17406825 DOI: 10.1007/s10620-007-9742-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
249 Sumberaz A, Centenaro M, Ansaldi F, Ancarani AO, Andorno E, Icardi G, Testino G. Relationship between laboratory parameters and intensive care unit stay post-liver transplantation: proposal of a model. Transplant Proc 2007;39:1868-70. [PMID: 17692636 DOI: 10.1016/j.transproceed.2007.05.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
250 Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 2007;13:1228-35. [PMID: 17763399 DOI: 10.1002/lt.21222] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
251 Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007;56:1283-90. [PMID: 17452425 DOI: 10.1136/gut.2006.102764] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 9.0] [Reference Citation Analysis]
252 Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007;13:1174-80. [PMID: 17663415 DOI: 10.1002/lt.21197] [Cited by in Crossref: 175] [Cited by in F6Publishing: 165] [Article Influence: 10.9] [Reference Citation Analysis]
253 Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007;13:1115-24. [PMID: 17663412 DOI: 10.1002/lt.21154] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
254 Biggins SW. Beyond the numbers: rational and ethical application of outcome models for organ allocation in liver transplantation. Liver Transpl 2007;13:1080-3. [PMID: 17663407 DOI: 10.1002/lt.21210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
255 Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol 2007;41:706-12. [PMID: 17667056 DOI: 10.1097/MCG.0b013e31802dabb3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
256 Taddei TH, Strazzabosco M. Hepatic venous pressure gradient (HVPG), serum sodium (SNa), and model of end-stage liver disease score (MELD): prognostic significance and correlations. J Clin Gastroenterol 2007;41:641-3. [PMID: 17667045 DOI: 10.1097/MCG.0b013e318051741d] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
257 Kettaneh A, Mario N, Fardet L, Flick D, Fozing T, Tiev K, Tolédano C, Cabane J. Mortalité hospitalière et durée de séjour des patients non programmés en médecine interne: valeur pronostique de paramètres biochimiques usuels à l'admission. La Revue de Médecine Interne 2007;28:443-9. [DOI: 10.1016/j.revmed.2007.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
258 Trotter JF. Impact of the Model for Endstage Liver Disease score on liver transplantation: . Current Opinion in Organ Transplantation 2007;12:294-7. [DOI: 10.1097/mot.0b013e32814f1ca0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
259 Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007;11:249-63. [PMID: 17606205 DOI: 10.1016/j.cld.2007.04.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
260 Said A, Einstein M, Lucey MR. Liver transplantation: an update 2007. Curr Opin Gastroenterol 2007;23:292-8. [PMID: 17414845 DOI: 10.1097/MOG.0b013e3280f9df41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
261 Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, Lee FY, Lee SD. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007;27:498-506. [PMID: 17403190 DOI: 10.1111/j.1478-3231.2007.01445.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
262 Ravaioli M, Masetti M, Ridolfi L, Capelli M, Grazi GL, Venturoli N, Di Benedetto F, Bianchi FB, Cavrini G, Faenza S, Begliomini B, Pinna AD, Gerunda GE, Ballardini G. Laboratory Test Variability and Model for End-Stage Liver Disease Score Calculation: Effect on Liver Allocation and Proposal for Adjustment. Transplantation 2007;83:919-24. [DOI: 10.1097/01.tp.0000259251.92398.2a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
263 Young AL, Rajagenashan R, Asthana S, Peters CJ, Toogood GJ, Davies MH, Lodge JPA, Pollard SG, Rajendra Prasad K. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transplant Int 2007;20:331-7. [DOI: 10.1111/j.1432-2277.2006.00441.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
264 Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805. [PMID: 17326206 DOI: 10.1002/hep.21563] [Cited by in Crossref: 1059] [Cited by in F6Publishing: 942] [Article Influence: 66.2] [Reference Citation Analysis]
265 Brown R Jr, Emond JC. Managing access to liver transplantation: implications for gastroenterology practice. Gastroenterology 2007;132:1152-63. [PMID: 17383434 DOI: 10.1053/j.gastro.2007.01.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
266 Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, Fisher RA. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007;13:30-7. [PMID: 17154400 DOI: 10.1002/lt.20906] [Cited by in Crossref: 185] [Cited by in F6Publishing: 176] [Article Influence: 11.6] [Reference Citation Analysis]
267 de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-vivaldi R, Alonso M. Model for End-Stage Liver Disease Score-Based Allocation of Donors for Liver Transplantation: A Spanish Multicenter Experience. Transplantation 2006;82:1429-35. [DOI: 10.1097/01.tp.0000244559.60989.5a] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
268 Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006;12:S128-36. [PMID: 17123284 DOI: 10.1002/lt.20979] [Cited by in Crossref: 146] [Cited by in F6Publishing: 129] [Article Influence: 8.6] [Reference Citation Analysis]
269 Angeli P, Wong F, Watson H, Ginès P; CAPPS Investigators. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2006;44:1535-42. [PMID: 17133458 DOI: 10.1002/hep.21412] [Cited by in Crossref: 275] [Cited by in F6Publishing: 228] [Article Influence: 16.2] [Reference Citation Analysis]
270 Biggins SW, Colquhoun S, Gish RG, Runyon BA. Model for end-stage liver disease (MELD) exception for ascites. Liver Transpl 2006;12:S88-90. [PMID: 17123288 DOI: 10.1002/lt.20963] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
271 Heine GH, Sester U, Köhler H. Volumenüberladung bei Herzinsuffizienz, nephrotischem Syndrom und Leberzirrhose. Internist 2006;47:1136-44. [DOI: 10.1007/s00108-006-1717-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
272 Fusai G, Dhaliwal P, Rolando N, Sabin CA, Patch D, Davidson BR, Burroughs AK, Rolles K. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation. Liver Transpl 2006;12:1626-33. [PMID: 16952166 DOI: 10.1002/lt.20870] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
273 Martín-llahí M, Guevara M, Ginès P. Hyponatremia in cirrhosis: clinical features and management. Gastroentérologie Clinique et Biologique 2006;30:1144-51. [DOI: 10.1016/s0399-8320(06)73492-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
274 Huo TI, Lin HC, Lee SD. Model for end-stage liver disease and organ allocation in liver transplantation: where are we and where should we go? J Chin Med Assoc. 2006;69:193-198. [PMID: 16835979 DOI: 10.1016/S1726-4901(09)70217-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
275 Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-61. [PMID: 16799946 DOI: 10.1002/lt.20824] [Cited by in Crossref: 219] [Cited by in F6Publishing: 186] [Article Influence: 12.9] [Reference Citation Analysis]
276 Chan HL, Chim AM, Lau JT, Hui AY, Wong VW, Sung JJ. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B. Am J Gastroenterol 2006;101:1516-23. [PMID: 16863555 DOI: 10.1111/j.1572-0241.2006.00659.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
277 Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, Zanello M, Cucchetti A, Tuci F, Del Gaudio M, Varotti G, Vetrone G, Trevisani F, Bolondi L, Pinna AD. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006;6:1572-7. [PMID: 16827857 DOI: 10.1111/j.1600-6143.2006.01354.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
278 Bennett J, Bromley P. Perioperative Issues in Pediatric Liver Transplantation: . International Anesthesiology Clinics 2006;44:125-47. [DOI: 10.1097/01.aia.0000210801.37760.70] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
279 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol 2006;22:254-62. [PMID: 16550040 DOI: 10.1097/01.mog.0000218962.93806.9a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
280 Said A, Lucey MR. Liver transplantation: an update. Curr Opin Gastroenterol 2006;22:272-8. [PMID: 16550042 DOI: 10.1097/01.mog.0000218964.70935.3c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
281 Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652-60. [PMID: 16697729 DOI: 10.1053/j.gastro.2006.02.010] [Cited by in Crossref: 487] [Cited by in F6Publishing: 513] [Article Influence: 28.6] [Reference Citation Analysis]
282 Londoño MC, Guevara M, Rimola A, Navasa M, Taurà P, Mas A, García-Valdecasas JC, Arroyo V, Ginès P. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130:1135-43. [PMID: 16618408 DOI: 10.1053/j.gastro.2006.02.017] [Cited by in Crossref: 139] [Cited by in F6Publishing: 145] [Article Influence: 8.2] [Reference Citation Analysis]
283 Silberhumer GR, Hetz H, Rasoul-rockenschaub S, Peck-radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival? Transplant Int 2006;19:275-81. [DOI: 10.1111/j.1432-2277.2006.00250.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
284 Schenker S, Bissell DM, Blei AT. Hepatology over the years. Hepatology 2006;43:S6-S12. [PMID: 16447280 DOI: 10.1002/hep.21061] [Reference Citation Analysis]
285 Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction. Transplantation. 2005;80:1414-1418. [PMID: 16340784 DOI: 10.1097/01.tp.0000181164.19658.7a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
286 Campbell M. Serum Sodium Predicts Mortality in Patients Listed for Liver Transplantation. Yearbook of Gastroenterology 2006;2006:290-291. [DOI: 10.1016/s0739-5930(08)70460-4] [Reference Citation Analysis]
287 Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12:65-71. [PMID: 16382473 DOI: 10.1002/lt.20560] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
288 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-31. [PMID: 16298014 DOI: 10.1016/j.jhep.2005.10.013] [Cited by in Crossref: 1854] [Cited by in F6Publishing: 1863] [Article Influence: 109.1] [Reference Citation Analysis]
289 Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, Navasa M, Bru C, Arroyo V, Rodés J, Ginès P. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005;129:1944-53. [PMID: 16344063 DOI: 10.1053/j.gastro.2005.09.024] [Cited by in Crossref: 185] [Cited by in F6Publishing: 197] [Article Influence: 10.3] [Reference Citation Analysis]
290 Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005;22:1079-89. [PMID: 16305721 DOI: 10.1111/j.1365-2036.2005.02691.x] [Cited by in Crossref: 259] [Cited by in F6Publishing: 256] [Article Influence: 14.4] [Reference Citation Analysis]
291 Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero LM. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005;42:793-801. [PMID: 16175621 DOI: 10.1002/hep.20871] [Cited by in Crossref: 174] [Cited by in F6Publishing: 128] [Article Influence: 9.7] [Reference Citation Analysis]
292 D'Amico G. Developing concepts on MELD: delta and cutoffs. J Hepatol 2005;42:790-2. [PMID: 15885348 DOI: 10.1016/j.jhep.2005.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
293 Freeman RB, Harper A, Edwards EB. Liver transplantation outcomes under the model for end-stage liver disease and pediatric end-stage liver disease: . Current Opinion in Organ Transplantation 2005;10:90-4. [DOI: 10.1097/01.mot.0000161760.02748.ce] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
294 Huo TI, Lee SD, Wu JC. Which is the holy grail in liver transplantation: hyponatremia, MELD, or a combination? Liver Transpl 2005;11:710; author reply 711. [PMID: 15915501 DOI: 10.1002/lt.20441] [Reference Citation Analysis]
295 Russo MW. MELD and serum sodium. Hepatology 2005;41:1198-9; author reply 1199; discussion 1199. [PMID: 15841448 DOI: 10.1002/hep.20676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
296 Cardenas A, Ginès P. Management of complications of cirrhosis in patients awaiting liver transplantation. J Hepatol 2005;42 Suppl:S124-33. [PMID: 15777567 DOI: 10.1016/j.jhep.2004.12.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]